A prospective observational study of prescription pattern in dermatology outpatient department of associated hospitals of Rajasthan University of Health Sciences-college of medical sciences, Jaipur
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20231118Keywords:
Antihistaminic, Antifungal, OPD, Prescription pattern, Skin diseasesAbstract
Background: Skin diseases are chronic in nature and they require lifetime treatment. Prescription pattern reflects health professional attitude towards the disease and role of drugs in its treatment. The study of prescription pattern is important to make medical care rational and monitoring adverse drug reactions.
Methods: An observational and prospective study was carried out in Skin and VD department along with department of pharmacology, RUHS college of medical sciences, Jaipur. Data collection was done in three months after ethical approval. Data was entered and analysed with latest Microsoft Excel version. Descriptive statistics were used to analyse the results.
Results: During the study period, a total of 979 prescriptions were included and analysed, out of which the usage of dermatological drugs was maximum among males (n=520, 53.11%). Total 2848 drugs were prescribed in 6 different dosage forms. The most common dosage form prescribed was tablet (1267, 44.49%) followed by cream (685, 24.05%). Total 1632 (57.30%) drugs were prescribed through oral route and 1216 (42.70%) drugs were prescribed through topical route. the present study depicted that dermatophytosis (n=243, 24.82%) was one of the most common dermatological manifestations. antihistaminic (673, 23.63%) were the most commonly prescribed drug.
Conclusions: The study of drug use is an effective tool to promote rational drug prescribing. Such type of study will help in formulation of proper antibiotics, drugs policy, prescription of cost-effective drugs, improvement in the patient compliance and reduction in undesirable effect of drugs.
Metrics
References
Pathak AK, Kumar S, Kumar M, Mohan L, Dikshit H. Study of Drug Utilization Pattern for Skin Diseases in Dermatology OPD of an Indian Tertiary Care Hospital - A Prescription Survey. J Clin Diag Res. 2016;10(2): 1-5.
Clark AF, Ghosh K, Tonnesen MG. Tissue engineering for cutaneous wounds. J Invest Dermatol. 2007;127: 1018-29.
Hay RJ, Johns NE, Williams HC, Bollinger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014; 134:1527-34.
Joel JJ, Jose N, Shastry CS. Patterns of skin disease and prescribing trends in rural India. Sch Acad J Pharm. 2013;2(4):304-9.
Boddepalli D. Prescription pattern of commonly used drugs in dermatology OPD at tertiary care hospital. Indian J Res. 2019;8(9):85-7.
Saravanakumar RT, Prasad GS, Ragul G. Study of prescribing pattern of topical corticosteroids in the multispecialty tertiary care teaching hospital in south India. Int J Res Pharm Sci. 2012;3(4):685.
Vineeta D, Sharad P, Ganachari MS, Geetanjali S, Santosh S. Assessment of drug prescribing pattern and cost analysis for skin disease in dermatological department of tertiary care hospital: An Interventional Study. J Pharmacovigil. 2015;4:211.
Motaghare VM, Bajait CS, Turnakar A, Sontakke SD, Chavan S. Prescription pattern and adverse drug reaction profile of drugs prescribed in dermatology out-patient department at a tertiary care teaching hospital. Ind J Pharm and Pharmacol. 2016;3(4):173-7.
Dayal SG, Gupta GP. A cross section of skin diseases in Bundelkhand region, UP. Indian J Dermatol Venereol Leprol. 1977;43:258-61.
Uppal R, Sharma SC, Bhowmik SR, Sharma PL, Kaur S. Topical corticosteroids usage in dermatology. Int J Pharm Therapy Toxicol. 1991;29:48-50.
Kushwaha A. Study the trends in dermatological disease and pattern of prescription in dermatology department of a tertiary care hospital. WJPPS. 2017; 6(8):1785-99.
Narwane SP, Patel TC, Shetty YC, Chikhalkar SB. Drug utilization and cost analysis for common skin diseases in dermatology opd of an indian tertiary care hospital -a prescription survey. Br J Pharma Res. 2011; 1(1):9-18.